TheProfitWatch

GNLX - Genelux Corporation Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.57 0.34 (7.55%) 0.0 (0.0%) 0.0 (-0.02%) 0.05 (1.13%) 0.0 (0.0%) 0.3 (6.62%) --- 0.0 (0.0%)

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.2
Diluted EPS:
-0.2
Basic P/E:
-24.575
Diluted P/E:
-24.575
RSI(14) 1m:
53.85
VWAP:
4.92
RVol:

Events

Period Kind Movement Occurred At

Related News